ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (NASDAQ:INHX); (the “Company”) today announced its financial results for the second quarter ended June 30, 2011 and provided an update on several recent clinical and corporate developments. As of June 30, 2011, the Company held $58 million in cash, cash equivalents and short and long-term investments. The Company reported a net loss in the second quarter of 2011 of $5.3 million or ($0.07) per share.
